Cannarma Trailokya Vijaya Vati - 30 Tablets - 500mg

Information About Cannarma Trailokya Vijaya Vati

Unlock the ancient power of Ayurveda with Trailokya Vijaya Vati, a potent herbal supplement crafted to support your overall health and vitality. Known for its traditional healing properties, this premium Ayurvedic formula is formulated with a blend of rare and natural ingredients that work in harmony to promote well-being.

Key Benefits:

The medicine has a direct effect on motor neurons, also known as 'Vaat Vaahini Naadi,' and therefore is a drug that provides quick relief, or ‘Aashukari,’ as per Ayurveda. Consequently, it provides quick results for the ailments related to various types of pain.

• Effective for chronic pains, joint pains, muscular spasms, and sciatica pain.
• Increases appetite, Curbs Insomnia & Anxiety, improves the quality of sleep, and controls seizures.
• Provides relief from Neuropathic pain.
• Mitigates the side effects of Chemotherapy. Effective for Renal colic & abdominal pains.
• Improves overall gut health, which helps to regulate the gut-brain axis.

Mechanism of Action:

CAUTION: Schedule E-1 drug. To be taken only under medical supervision

Chronic Pain: Cannabinoids produce analgesia by acting on multiple pain targets within the peripheral and CNS by activating specific receptors throughout the body, in particular CB1, which are found predominantly in the CNS, and CB2 receptors found in cells involved with the immune system. Besides acting on cannabinoid CB1/CB2, they may reduce pain through interaction with the putative non-CB1/CB2 cannabinoid G protein-coupled receptors (GPCR55 or GPCR18) and opioid or serotonin (5-HT) receptors.

Appetite: Hunger levels are determined by a substance in the human body called ghrelin, which is known as the ‘hunger hormone’. The hormone is released by the stomach, intestines, and brain, as it stimulates and manages appetite. Cannabis triggers ghrelin levels and stimulates appetite. 

IBS, Vomiting, Diarrhoea: Cannabinoids predominantly mediate inhibitory pathways in the gastrointestinal tract through the reduction of vagal cholinergic tone. CB2 modulates inflammation, whereas CB1 controls central functions, including pain control, satiety, nausea, and vomiting. The distribution and concentration of the endocannabinoid system in specific tissues demonstrate the physiology of cannabinoids in the gastrointestinal tract and offer possible drug targets for the management of inflammatory bowel disease.

How to Use: Take the recommended dosage as per the instructions provided or as directed by an Ayurvedic healthcare practitioner for best results.